Live from the NIH registry
Studies recruiting near Ocala right now
Top 25 of 134 recruiting studies, sorted by proximity — each links to its official registry page
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Ocala, Florida (0.9 mi)
· Sponsor: GlaxoSmithKline
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Non-small Cell Lung Cancer, Melanoma
Phase 1
Interventional 174 participants sought
Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.0 mi)
· Sponsor: Janssen Research & Development, LLC
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (22.6 mi)
· Sponsor: Boehringer Ingelheim
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Melanoma, Non-small Cell Lung Cancer
Phase 2
Interventional 178 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Phase 2
Interventional 200 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Ocala, Florida (0.9 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: 89bio, Inc.
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 2
Interventional 360 participants sought
Charter Research - The Villages /ID# 282376 — The Villages, Florida (20.4 mi)
· Sponsor: AbbVie
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (22.7 mi)
· Sponsor: Eli Lilly and Company
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Wildwood Clinical Research / Florida Retina Institute — Wildwood, Florida (22.6 mi)
· Sponsor: EyeBiotech Ltd.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Ocala, Florida (0.9 mi)
· Sponsor: American Society of Clinical Oncology
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Renstar Medical Research - Ocala - Northeast 1st Avenue- Site Number : 8400021 — Ocala, Florida (0.9 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
Pan Tumor Rollover Study
Cancer
Phase 2
Interventional 1,500 participants sought
Florida Cancer Affiliates — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
Healthy Participants, Dyslipidemia
Phase 1
Interventional 136 participants sought
Research Site — Inverness, Florida (26.0 mi)
· Sponsor: AstraZeneca
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Tizona Therapeutics, Inc
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
K2 Medical Research — Lady Lake, Florida (22.7 mi)
· Sponsor: Lantheus Biosciences Ltd.
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 734 participants sought
Florida Cancer Affiliates - Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: NovoCure GmbH
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Hypercholesterolemia
Phase 2
Interventional 420 participants sought
K2 Medical Research The Villages — The Villages, Florida (20.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Phase 3
Interventional 426 participants sought
Local Institution - 1608 — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Ocala, Florida (0.9 mi)
· Sponsor: GlaxoSmithKline